SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Secondary pharmaceutical patenting: A global perspective
11 references·6 citing·46 second hop
Secondary pharmaceutical patenting: A global perspective (2017)Secondary pharmaceutical patenting: A glo…What Is the Probability of Receiving a US Patent? (2016)What Is the Probability of Re…Intellectual Property in the Twenty-First Century: Will the Developing Countries Lead or Follow?* (2014)Intellectual Property in the …Innovation and Its Discontents (2011)Innovation and Its DiscontentsExaminer Characteristics and Patent Office Outcomes (2011)Examiner Characteristics and …The Global Governance of Knowledge: Patent Offices and their Clients (2010)The Global Governance of Know…Knowledge sources, patent protection, and commercialization of pharmaceutical innovations (2010)Knowledge sources, patent pro…Variation in Institutional Strength (2009)Variation in Institutional St…Harmonization and Its Discontents: A Case Study of TRIPS Implementation in India's Pharmaceutical Sector (2009)Harmonization and Its Discont…Innovation and Its Discontents: How Our Broken Patent System Is Endangering Innovation and Progress, and What to Do About It (2005)Innovation and Its Discontent…Ending Abuse of Patent Continuations (2003)Ending Abuse of Patent Contin…How to Count Patents and Value Intellectual Property: The Uses of Patent Renewal and Application Data (1998)How to Count Patents and Valu…What is the impact of intellectual property rules on access to medicines? A systematic review (2022)What is the impact of intelle…The contribution of intellectual capital to financial stability in Indian pharmaceutical companies (2020)The contribution of intellect…Patents, Innovation, and Development (2020)Patents, Innovation, and Deve…Patents, Innovation, and Development (2020)Patents, Innovation, and Deve…Is the Patent System the Way Forward with the CRISPR-Cas 9 Technology? (2020)Is the Patent System the Way …Indian pharmaceutical patent prosecution: The changing role of Section 3(d) (2018)Indian pharmaceutical patent …On the Complex Economics of Patent Scope (1990)The Economics of Science (2010)Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry (2016)Papers and patents are becoming less disruptive over time (2023)Efficient Capital Markets: A Review of Theory and Empirical Work (1970)EFFICIENT CAPITAL MARKETS: A REVIEW OF THEORY AND EMPIRICAL WORK* (1970)The Theory of Economic Development (2003)Into the valley of death: research to innovation (2013)What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry (2016)Artificial intelligence and innovation capability: A dynamic capabilities perspective (2025)A Penny for Your Quotes: Patent Citations and the Value of Innovations (1990)Patent Statistics as Economic Indicators: A Survey (1990)Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations (1993)The Economics of Patents: Lessons from Recent U.S. Patent Reform (2002)Patent Statistics as an Innovation Indicator (2010)Institutions, Institutional Change and Economic Performance (1990)The New Institutionalism in Organizational Analysis. (1993)Increasing Returns, Path Dependence, and the Study of Politics (2000)Hierarchical Capitalism in Latin America: Business, Labor, and the Challenges of Equitable Development (2013)Making Constitutions (2013)Critical junctures and institutional change (2015)Probabilistic Patents (2005)Patent Citations as a Measure of Knowledge Flows: The Influence of Examiner Citations (2006)Monitoring global supply chains (2015)The University of Chicago Law Review (2017)Machine learning and human capital complementarities: Experimental evidence on bias mitigation (2020)Work‐from‐anywhere : The productivity effects of geographic flexibility (2020)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools (2001)The Patent Paradox Revisited: An Empirical Study of Patenting in the U.S. Semiconductor Industry, 1979-1995 (2001)Foreign Competition and Domestic Innovation: Evidence from U.S. Patents (2016)Patent examiner specialization (2018)Small Innovators: No Risk, No Return (2018)Access to Essential Drugs in Poor Countries (1999)Appraising the Evidence: Reviewing Disparate Data Systematically (2002)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)The Logic of Collective Action. (1966)Institutions, Institutional Change and Economic Performance (1991)Paradigm shift in the global IP regime: The agency of academics (2013)The Odyssey of the Regulatory State: From a “Thin” Monomorphic Concept to a “Thick” and Polymorphic Concept (2013)An Integrated Model of Legal Transplantation: The Diffusion of Intellectual Property Law in Developing Countries (2014)The public domain: enclosing the commons of the mind (2009)Co-ownership of intellectual property: Exploring the value-appropriation and value-creation implications of co-patenting with different partners (2013)Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents (2012)Theorizing Transnational Legal Ordering (2016)Neoliberal regime change and the remaking of global health: from rollback disinvestment to rollout reinvestment and reterritorialization (2019)
this work references cited by second hop

References

  • 1998How to Count Patents and Value Intellectual Property: The Uses of Patent Renewal and Application Data696 cited
  • 2011Innovation and Its Discontents678 cited
  • 2009Variation in Institutional Strength534 cited
  • 2005Innovation and Its Discontents: How Our Broken Patent System Is Endangering Innovation and Progress, and What to Do About It475 cited
  • 2011Examiner Characteristics and Patent Office Outcomes236 cited
  • 2009Harmonization and Its Discontents: A Case Study of TRIPS Implementation in India's Pharmaceutical Sector158 cited
  • 2010Knowledge sources, patent protection, and commercialization of pharmaceutical innovations140 cited
  • 2010The Global Governance of Knowledge: Patent Offices and their Clients117 cited
  • 2016What Is the Probability of Receiving a US Patent?116 cited
  • 2003Ending Abuse of Patent Continuations81 cited
  • 2014Intellectual Property in the Twenty-First Century: Will the Developing Countries Lead or Follow?*79 cited

Cited by

  • 2022What is the impact of intellectual property rules on access to medicines? A systematic review85 cited
  • 2020The contribution of intellectual capital to financial stability in Indian pharmaceutical companies69 cited
  • 2020Patents, Innovation, and Development57 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2018Indian pharmaceutical patent prosecution: The changing role of Section 3(d)53 cited
  • 2020Patents, Innovation, and Development42 cited
  • 2020Is the Patent System the Way Forward with the CRISPR-Cas 9 Technology?9 cited